Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded tRNA-Trp is a small, non-coding RNA molecule transcribed from the mitochondrial genome that functions as the transfer RNA for tryptophan during mitochondrial protein synthesis[3]. This tRNA recognizes and decodes the UGA codon as tryptophan in the mitochondrial genetic code—a deviation from the nuclear code—enabling translation of key subunits of respiratory chain complexes[1]. Post-transcriptional modifications such as the addition of 5-taurinomethyluridine at the wobble position are essential for its function and stability[1][2]. Mutations in MT-TW may lead to defective mitochondrial translation, combined oxidative phosphorylation deficiencies, and are implicated in mitochondrial myopathies and multisystemic mitochondrial disorders[2][4]. While MT-TW is not considered a conventional therapeutic target like receptors or enzymes, detection of pathogenic mutations serves as a clinically relevant biomarker for mitochondrial disease diagnosis and monitoring[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded transfer RNA for tryptophan (MT-TW).